{
    "ticker": "BYSI",
    "name": "Beyond Air, Inc.",
    "description": "Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company focused on developing innovative therapies for patients with respiratory diseases. Founded in 2011, Beyond Air aims to revolutionize the treatment of respiratory conditions through its proprietary technology that delivers nitric oxide directly to the lungs. The company's lead product candidate, the LungFit\u2122 device, is designed to provide a safe and effective inhaled nitric oxide therapy for patients with conditions such as asthma, pulmonary hypertension, and other serious respiratory ailments. Beyond Air is committed to advancing the science of nitric oxide therapy, leveraging its expertise in medical device development and regulatory navigation to bring new treatments to market. The company\u2019s mission is to improve patient outcomes and quality of life through groundbreaking respiratory therapies that are accessible and effective. Beyond Air is also focused on expanding its product pipeline, exploring various indications for its technology and potential partnerships to enhance its therapeutic offerings.",
    "industry": [
        "Medical Devices",
        "Biopharmaceuticals"
    ],
    "headquarters": "New York, New York, USA",
    "founded": "2011",
    "website": "https://www.beyondair.net",
    "ceo": "Steve Lisi",
    "social_media": {
        "twitter": "https://twitter.com/BeyondAirInc",
        "linkedin": "https://www.linkedin.com/company/beyond-air/"
    },
    "investor_relations": "https://ir.beyondair.net",
    "key_executives": [
        {
            "name": "Steve Lisi",
            "position": "CEO"
        },
        {
            "name": "Michael E. M. B. P. O'Neil",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Medical Devices",
            "products": [
                "LungFit\u2122"
            ]
        }
    ],
    "seo": {
        "meta_title": "Beyond Air, Inc. | Innovative Respiratory Therapies",
        "meta_description": "Beyond Air, Inc. focuses on developing advanced therapies for respiratory diseases, including inhaled nitric oxide treatments. Learn about our innovations and mission.",
        "keywords": [
            "Beyond Air",
            "Respiratory Diseases",
            "Nitric Oxide Therapy",
            "LungFit",
            "Medical Devices"
        ]
    },
    "faq": [
        {
            "question": "What is Beyond Air known for?",
            "answer": "Beyond Air is known for its innovative therapies for respiratory diseases, particularly its LungFit\u2122 device that delivers inhaled nitric oxide."
        },
        {
            "question": "Who is the CEO of Beyond Air?",
            "answer": "Steve Lisi is the CEO of Beyond Air, Inc."
        },
        {
            "question": "Where is Beyond Air headquartered?",
            "answer": "Beyond Air is headquartered in New York, New York, USA."
        },
        {
            "question": "What are Beyond Air's main products?",
            "answer": "Beyond Air's main product is the LungFit\u2122, a medical device for delivering inhaled nitric oxide therapy."
        },
        {
            "question": "When was Beyond Air founded?",
            "answer": "Beyond Air was founded in 2011."
        }
    ],
    "competitors": [
        "NVCR",
        "PAVM",
        "INSP"
    ],
    "related_stocks": [
        "AXGN",
        "MDGL",
        "BMRN",
        "AVEO"
    ]
}